What Causes T- and B-Cell Negative SCID?

Severe combined immunodeficiency characterized by the simultaneous absence of functional T and B lymphocytes is most commonly caused by genetic mutations that disrupt critical stages of early lymphocyte receptor assembly or cellular metabolism. In clinical immunology, this phenotype is classified as T-minus B-minus SCID and typically stems from defects in V(D)J recombination, non-homologous end joining repair mechanisms, or adenosine deaminase deficiency. Without these fundamental molecular processes, lymphoid progenitor cells undergo developmental arrest and apoptosis before maturing into functional adaptive immune cells.

Disruptions in V(D)J Recombination

The most prevalent causes of combined T- and B-cell developmental arrest are mutations in the recombination-activating genes, specifically RAG1 and RAG2. During normal lymphocyte ontogeny in the bone marrow and thymus, the RAG endonuclease complex recognizes recombination signal sequences flanking variable (V), diversity (D), and joining (J) gene segments.

The RAG complex introduces targeted double-strand breaks to assemble functional T-cell receptor (TCR) and B-cell receptor (BCR) genes. When deleterious mutations occur in either RAG1 or RAG2:

  • DNA cleavage cannot occur at recombination signal sequences.
  • Pre-TCR and pre-BCR complexes fail to assemble.
  • Developing thymocytes and pro-B cells cannot receive essential survival signals.
  • The cells undergo rapid apoptotic clearance, resulting in a classic T-B-NK+ immunophenotype.

Defects in the Non-Homologous End Joining Pathway

Following DNA cleavage by RAG proteins, double-strand breaks must be repaired by the ubiquitous non-homologous end joining (NHEJ) machinery. Deficiencies in proteins dedicated to processing and joining these hairpin ends lead to radiosensitive SCID.

Key molecular components associated with this failure include:

  • Artemis (encoded by DCLRE1C): An endonuclease phosphorylated and activated by DNA-dependent protein kinase catalytic subunit (DNA-PKcs). Artemis opens DNA hairpins formed by RAG cleavage. Mutations in DCLRE1C prevent hairpin opening, stalling both TCR and BCR gene rearrangement.
  • DNA-PKcs (encoded by PRKDC): Required for recruiting and activating Artemis at double-strand break sites.
  • DNA Ligase IV (LIG4) and XRCC4: Form the final ligation complex that joins processed DNA ends.

Because NHEJ is essential for general DNA repair, mutations affecting these proteins often produce hypersensitivity to ionizing radiation alongside the T-B- SCID phenotype.

Adenosine Deaminase Deficiency

Adenosine deaminase (ADA) deficiency accounts for approximately 10 to 15 percent of all SCID cases and represents an inborn error of purine metabolism. ADA catalyzes the irreversible deamination of adenosine and 2'-deoxyadenosine to inosine and 2'-deoxyinosine, respectively.

When ADA is absent or defective:

  • Deoxyadenosine accumulates and is converted intracellularly into deoxyadenosine triphosphate (dATP).
  • Elevated concentrations of dATP allosterically inhibit ribonucleotide reductase.
  • The inhibition of ribonucleotide reductase depletes intracellular deoxynucleoside triphosphate (dNTP) pools, shutting down cellular DNA synthesis and repair.
  • Toxic levels of S-adenosylhomocysteine hydrolase inhibition lead to generalized lymphoid cell death.

Unlike purely recombinatorial defects, metabolic accumulation of dATP is toxic across all lymphoid lineages, frequently leading to a combined depletion of T cells, B cells, and natural killer (NK) cells (T-B-NK- SCID).

Clinical Presentation and Diagnostic Findings

Patients with combined T- and B-cell developmental failure typically present in early infancy with recurrent, life-threatening opportunistic infections, chronic diarrhea, failure to thrive, and severe lymphopenia. Newborn screening panels detect these conditions via low or absent T-cell receptor excision circles (TRECs) and kappa-deleting recombination excision circles (KRECs). Definitive management requires urgent protective isolation, antimicrobial prophylaxis, and curative intervention through allogeneic hematopoietic stem cell transplantation or targeted gene therapy.